THERAVANCE BIOPHARMA INC's ticker is TBPH and the CUSIP is G8807B106. A total of 116 filers reported holding THERAVANCE BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $292,919 | -16.6% | 33,942 | 0.0% | 0.00% | -33.3% |
| Q2 2023 | $351,300 | +2.1% | 33,942 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $344,172 | +6.1% | 33,942 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $324,486 | +34.4% | 33,942 | +55.3% | 0.00% | 0.0% |
| Q4 2021 | $241,465 | +397.9% | 21,852 | +233.4% | 0.00% | – |
| Q3 2021 | $48,500 | -87.2% | 6,554 | -64.6% | 0.00% | -100.0% |
| Q1 2021 | $378,075 | +20.3% | 18,524 | -12.8% | 0.00% | +33.3% |
| Q3 2020 | $314,240 | -29.6% | 21,254 | 0.0% | 0.00% | -40.0% |
| Q2 2020 | $446,121 | -12.5% | 21,254 | +7.9% | 0.01% | 0.0% |
| Q4 2019 | $509,774 | – | 19,690 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Link Fund Solutions Ltd | 5,251,349 | $135,459,000 | 69.86% |
| Chescapmanager LLC | 949,006 | $24,570,000 | 3.61% |
| Baupost Group | 9,309,168 | $241,014,000 | 2.66% |
| Rock Springs Capital Management LP | 655,200 | $16,963,000 | 0.54% |
| Rubric Capital Management LP | 173,400 | $4,489,000 | 0.51% |
| Newtyn Management, LLC | 173,300 | $4,487,000 | 0.41% |
| NJ State Employees Deferred Compensation Plan | 38,142 | $988,000 | 0.17% |
| King Wealth Management Group | 22,500 | $583,000 | 0.15% |
| Virtus ETF Advisers LLC | 29,216 | $756,000 | 0.12% |
| Tekla Capital Management LLC | 117,725 | $3,048,000 | 0.12% |